HOME >> BIOLOGY >> NEWS
Companies license real-time pathogen detection technology developed at Kent State, NEOUCOM

Innovative technology developed at Northeastern Ohio Universities College of Medicine (NEOUCOM) and Kent State University with the capability of detecting bioterrorism agents and pathogens in food and water has led to two licensing agreements.

These agreements bring the promise of new jobs and economic expansion in northeast Ohio and the state.

Liquid crystal biosensor technology developed through a joint research project by investigators at NEOUCOM and Kent State has been co-licensed to two companies, Oringen LLC of Tallmadge, Ohio, and Pathogen Detection Systems of Boulder, Colo., for further development.

Continued development of this technology will enhance the health, safety and economic vitality of Ohio communities and the nation. Each company has committed to bringing research and development, production, sales and other jobs to Kent and surrounding areas, once the technology has been developed.

The liquid crystal biosensor technology is expected to change radically the detection and identification of harmful pathogens. While current detection methods can take up to three days to identify disease-causing agents, this new technology offers the promise of detection and identification within minutes.

The collaborating researchers combined their expertise in liquid crystals and biomedical sciences to develop a device that can quickly detect harmful microbes, such as anthrax or plague. There are a host of potential applications for this technology, including environmental protection, homeland security and medical diagnoses.

Christopher Woolverton, Ph.D., Kent State associate professor of biological sciences, Gary D. Niehaus, Ph.D., NEOUCOM associate professor of physiology and pharmacology, Oleg D. Lavrentovich, Ph.D., director of Kent State's Liquid Crystal Institute, and Kathleen Doane, Ph.D., NEOUCOM associate professor of anatomy, formed the team of investigators that produced a portfolio of patents and, u
'"/>

Contact: Lisa Lambert
lalamber@kent.edu
330-672-8514
Kent State University
1-Mar-2006


Page: 1 2 3

Related biology news :

1. Wanted: Companies to license life-saving breath test developed at NJIT
2. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
3. Macrochem acquires option to license pexiganan
4. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
5. University of Colorado influenza chip licensed by Quidel Corp. of San Diego
6. Rensselaer licenses microscope technology to Thorlabs
7. Columbia University licenses next-generation DNA sequencing technology
8. Case Western Reserve University licenses methoxyamine to Tracon
9. Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan
10. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
11. Yale ovarian cancer detection technology licensed in China by SurExam

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
Breaking Biology Technology:
Cached News: